Si-Bone (SIBN) Cash from Financing Activities (2017 - 2026)
Si-Bone (SIBN) recorded quarterly Cash from Financing Activities of $34000.0 in Q1 2026, down 96.7% quarter-over-quarter from $1.0 million in Q4 2025, and down 66.99% on a YoY basis from $103000.0 in Q1 2025.
Si-Bone (SIBN) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Si-Bone's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at $34000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 66.99% year-over-year to $34000.0; the TTM figure through Mar 2026 stood at $3.3 million (up 69.07% YoY), while the FY2025 annual figure was $3.4 million, up 72.42% from the prior year.
- Cash from Financing Activities was $34000.0 for Q1 2026 at Si-Bone, down from $1.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $89.1 million in Q2 2023 to a low of -$237000.0 in Q3 2023.
- Historically, Cash from Financing Activities has averaged $5.8 million across 5 years, with a median of $169000.0 in 2022.
- Biggest YoY gain for Cash from Financing Activities was 7151.67% in 2023; the steepest drop was 323.58% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at $693000.0 in 2022, then grew by 21.5% to $842000.0 in 2023, then plunged by 109.26% to -$78000.0 in 2024, then jumped by 1419.23% to $1.0 million in 2025, then sank by 96.7% to $34000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $34000.0 (Q1 2026), $1.0 million (Q4 2025), and $11000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Si-Bone | 696.98 Mn | 556.86 Mn | 41.94 Mn | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 1.03 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 103,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | -78,000.00 |
| Dec 31, 2024 | -78,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 105,000.00 |
| Mar 31, 2024 | 105,000.00 |
| Dec 31, 2023 | 842,000.00 |
| Dec 31, 2023 | 842,000.00 |